Back to results
US 2023/0402129 A1Published application
A method of epitope-based vaccine design
AssigneesThe University of British Columbia, The James Hutton Institute
InventorsWilfred Jefferies, Paolo Ribeca
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of epitope-based vaccine design. The method comprising: a) providing one or more target amino acid sequence(s); b) optionally discarding peptides based on one or more predetermined features; c) parsing and selecting MHC I and/or MHC II binding peptides from said sequences; and d) assembling the MHC I and/or MHC II binding peptides optionally with linkers to produce an assembly of peptides.
Claims15
A method of epitope-based vaccine design comprising:
- providing target amino acid sequence(s) and annotation;
- a list of genomic features to be excluded from the result;
- a list of alleles which describe the population to be vaccinated;
- filtering peptides based on their antigenic score;
- filtering peptides based on their similarity with peptides from the population to be vaccinated, wherein optionally the peptides from the population to be vaccinated are wild-type peptides;
- filtering peptides based on a database of known genomic features;
- visualising the filtering process graphically in order to do quality control;
- for all the selected peptide lengths:
- predict immunogenic peptides for the immune system of the species targeted by the vaccine (for human vaccines, predict immunogenic MHC-I and MHC-II peptides) based on population structure;
- selecting peptides based on the p-value returned by the predictor;
- recombining peptides produced for different peptide lengths;
- generating statistics on:
- the number and lengths of peptides needed for each gene and the alleles in the population covered by each peptide;
- optionally selecting the peptides coming from “denser” genes in order to compact the construct;
- and
- assembling the peptides optionally with linkers.
13 more elements
A method of epitope-based vaccine design comprising:
- a) providing one or more target amino acid sequence(s);
- b) optionally discarding peptides based on one or more predetermined features;
- c) parsing and selecting immunogenic peptides from said sequences (in the case of human vaccines, MHC I and/or MHC II binding peptides);
- and
- d) assembling the immunogenic peptides optionally with linkers to produce an assembly of peptides.
2 more elements
Dependencies are inferred from the claim text.